Michael Graham Walker

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 6 EPO patents, primarily in Gene Expression Profiling. Top assignees: Incyte Genomics, Inc., Affymetrix, Inc., Genomic Health, Inc.. Active years: 1998-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Graham Walker. Retrieved from https://idiyas.com/inventor/michael-graham-walker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 1)

% Patents Active = 85.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 866(Granted Patents)

Location History:

Sunnyvale, CA (US) (1998 - 2019)
Carlsbad, CA (US) (2023)

Company Filing History:

6 out of 163

Incyte Genomics, Inc.

Incyte Pharmaceuticals, Inc.

Octave Bioscience, Inc.

patent

Years Active: 1998-2023

Loading Chart...

Areas of Expertise:

Gene Expression Profiling

Multiple Sclerosis

Tumor Tissues

Nucleic Acid Probes

Sequence Database

Polynucleotides

Aquaporin-8

Bone Remodeling

Biomolecular Sequences

Kidney Diseases

Ras Proteins

Probability Base Calling

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11773446 - Methods for assessment of multiple sclerosis activity (2023-10-03),

2. 10241114 - Gene expression profiling in biopsied tumor tissues (2019-03-26),

3. 8071286 - Gene expression profiling in biopsied tumor tissues (2011-12-06),

4. 7858304 - Gene expression profiling in biopsied tumor tissues (2010-12-28),

5. 7838224 - Gene expression profiling in biopsied tumor tissues (2010-11-23),

6. 7081340 - Gene expression profiling in biopsied tumor tissues (2006-07-25),

7. 6957149 - Computer-aided probability base calling for arrays of nucleic acid probes on chips (2005-10-18),

8. 6633817 - Sequence database search with sequence search trees (2003-10-14),

9. 6602667 - Inflammation-associated polynucleotides (2003-08-05),

10. 6566066 - Aquaporin-8 variant (2003-05-20),

11. 6546340 - Computer-aided probability base calling for arrays of nucleic acid probes on chips (2003-04-08),

12. 6524799 - DNA encoding sparc-related proteins (2003-02-25),

13. 6485910 - Ras association domain containing protein (2002-11-26),

14. 6426186 - Bone remodeling genes (2002-07-30),

15. 6389428 - System and method for a precompiled database for biomolecular sequence information (2002-05-14),

Title: Michael Graham Walker: Pioneering Innovations in Cancer Research

Introduction

Michael Graham Walker, based in Sunnyvale, California, is an esteemed inventor known for his significant contributions to cancer research. With an impressive portfolio of 19 patents, Walker’s work primarily focuses on gene expression profiling, which plays a crucial role in the diagnosis and personalized treatment of breast cancer.

Latest Patents

Walker’s latest patents include groundbreaking methods for gene expression profiling in biopsied tumor tissues. These inventions involve sensitive techniques to measure mRNA levels in various biopsy materials, including archived paraffin-embedded specimens. Importantly, the patents cover gene sets related to breast cancer that are essential for determining optimal treatment options based on gene expression studies.

Career Highlights

Throughout his career, Walker has held key positions in prominent companies, notably at Incyte Genomics, Inc. and Affymetrix, Inc. His work at these institutions has been instrumental in advancing genomic technology and its application in clinical settings.

Collaborations

Walker’s innovative journey includes collaborations with notable colleagues such as Robert J. Lipshutz and Joffre B. Baker. These partnerships have fostered a dynamic exchange of ideas, contributing to the success of their collective research endeavors.

Conclusion

Michael Graham Walker continues to make valuable contributions to the field of cancer research through his innovative patents and collaborations. His work has the potential to greatly enhance diagnostics and treatment options for breast cancer patients, underscoring the transformative impact of his inventions in the medical community.

Profile summary based on public USPTO records.